Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Biotechnol Prog. 2018 Mar 31;34(4):1045–1058. doi: 10.1002/btpr.2629

Figure 1. Experimental design.

Figure 1

TNF-α: tumor necrosis factor α; IL-1β: interleukin 1β; MCM: macrophage conditioned medium; ADA: adalimumab; IFX: infliximab; ETA: etanercept; ANA: anakinra; GAG: glycosaminoglycans; OHP: hydroxyproline.